IA
ACHV icon

IFP Advisors’s Achieve Life Sciences ACHV Stock Holding History

IFP Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8
Closed -$23 – 4837
2025
Q1 		$21 Hold
8
– – ﹤0.01% 4156
2024
Q4 		$28 Buy
+8
New +$36 ﹤0.01% 4394

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IFP Advisors's ACHV Position: Q2 2025 in Review

IFP Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 8 shares — an estimated $23 sold.

IFP Advisors first reported a position in ACHV in Q4 2024 and held it in 2 quarters. The position peaked at $28 in Q4 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • IFP Advisors reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 8 Achieve Life Sciences shares in Q2 2025, an estimated $23.
  • IFP Advisors first reported a position in Achieve Life Sciences in Q4 2024 and held it in 2 quarters.
  • IFP Advisors's Achieve Life Sciences position peaked at $28 in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.